arsenic trioxide has been researched along with Adenocarcinoma in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (54.55) | 29.6817 |
| 2010's | 13 (39.39) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, K; Fujii, N; Maeda, Y; Matsuoka, H; Matsuoka, KI; Nakamura, K; Nishimori, H; Sugiura, H | 1 |
| Chen, HY; Dai, HM; Gu, SY; Li, XY; Zhang, ZZ | 1 |
| Cai, H; Li, X; Wang, J | 1 |
| Chen, C; Jiang, X; Ren, Y; Zhang, Z | 1 |
| Ho, JC; Kwong, YL; Lam, SK; Li, YY; Mak, JC; Zheng, CY | 1 |
| Jiang, M; Li, YH; Liu, LX; Ma, ZB; Xu, HY; Yang, YL | 1 |
| Ho, JC; Lam, SK; Leung, LL; Li, YY; Zheng, CY | 1 |
| Chen, C; Gu, S; Jiang, X; Zhang, Z | 3 |
| An, B; Hao, Y; Li, L; Song, G; Wang, L; Wang, Y; Wei, T; Yin, C | 1 |
| Chen, H; Dai, H; Gu, S; Li, X; Zhang, Z | 1 |
| Han, YH; Kim, SH; Kim, SZ; Park, WH | 1 |
| Nelson, R; Self, WT; Talbot, S | 1 |
| Dong, D; Fu, S; Wang, G; Wang, X; Yang, B | 1 |
| Aklilu, M; Kindler, HL; Nattam, S; Vokes, EE | 1 |
| Hou, K; Hu, X; Li, Y; Liu, J; Liu, Y; Qu, J; Qu, X; Teng, Y; Zhang, Y | 1 |
| Liu, H; Qiu, J; Wu, YP | 1 |
| Li, B; Liu, YA; Qu, GP; Xiu, QY; Zhang, LZ | 1 |
| Han, YH; Kim, SH; Kim, SZ; Moon, HJ; Park, WH; You, BR | 2 |
| Hock, JM; Li, X; Liu, Y; Van Beneden, RJ | 1 |
| Chen, F; Jiang, M; Mo, BW; Wang, CM; Wang, JY; Zhao, XQ | 1 |
| Huang, C; Jiang, SJ; Lei, ML; Li, HC; Mu, XY; Wang, CX; Wang, LF | 1 |
| Adrian, TE; Ding, X; Li, X | 1 |
| Wang, XW; Wei, L; Zuo, WS | 1 |
| Ke, JJ; Ling, ZQ; Shao, QS; Ye, ZY | 1 |
| Chang, LW; Cheng, Y; Tsou, TC | 1 |
| Goldberg, SN; Hines-Peralta, A; Liu, ZJ; Regan, M; Signoretti, S; Sukhatme, V | 1 |
| Au, WY; Chan, EY; Cheng, VC; Kumana, CR; Kwong, YL; Lam, CW; Liu, R; Shek, TW | 1 |
| Han, JG; Li, BX; Xue, YW; Yang, BF | 1 |
| Li, B; Qu, GP; Shen, J; Xiu, QY | 1 |
| Liang, X; Lin, C; Xu, M | 1 |
1 review(s) available for arsenic trioxide and Adenocarcinoma
| Article | Year |
|---|---|
Arsenic trioxide in the treatment of platinum-resistant recurrent endometrial cancer: a case report and literature review.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Arsenic Trioxide; Endometrial Neoplasms; Female; Humans; Neoplasm Recurrence, Local | 2020 |
1 trial(s) available for arsenic trioxide and Adenocarcinoma
| Article | Year |
|---|---|
Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oxides; Pancreatic Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome | 2008 |
31 other study(ies) available for arsenic trioxide and Adenocarcinoma
| Article | Year |
|---|---|
Successful Treatment of Acute Promyelocytic Leukemia Complicated with Endometrial Cancer by Arsenic Trioxide.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Arsenic Trioxide; Endometrial Neoplasms; Female; Humans; Leukemia, Promyelocytic, Acute | 2021 |
[miR-155/BACH1 Signaling Pathway in Human Lung Adenocarcinoma Cell Death Induced by Arsenic Trioxide].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Apoptosis; Arsenic Trioxide; Arsenicals; Basic-Leucine Zipper Transcription Factors; Cell Death; Cell Line, Tumor; Heme Oxygenase-1; Humans; Lung Neoplasms; MicroRNAs; NAD(P)H Dehydrogenase (Quinone); Oxides; Signal Transduction | 2017 |
Arsenic trioxide co-exposure potentiates benzo(a)pyrene genotoxicity by enhancing the oxidative stress in human lung adenocarcinoma cell.
Topics: Adenocarcinoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzo(a)pyrene; Cell Line, Tumor; DNA Damage; Drug Synergism; Humans; Lung Neoplasms; Oxidative Stress; Oxides | 2013 |
Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Liver Neoplasms, Experimental; Lung Neoplasms; Mice; Mice, Nude; Oxides; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2014 |
Arsenic trioxide induces apoptosis of human gastrointestinal cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Drug Administration Schedule; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Oxides; Proto-Oncogene Proteins c-bcl-2; Time Factors; Treatment Outcome; Tumor Suppressor Protein p53 | 2014 |
E2F1 downregulation by arsenic trioxide in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Oxides; United States; United States Food and Drug Administration; Xenograft Model Antitumor Assays | 2014 |
Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Synergism; Humans; Lung Neoplasms; Oxidative Stress; Oxides; Resveratrol; Stilbenes | 2015 |
Arsenic trioxide inhibits breast cancer cell growth via microRNA-328/hERG pathway in MCF-7 cells.
Topics: 3' Untranslated Regions; Adenocarcinoma; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Binding Sites; Breast Neoplasms; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; HEK293 Cells; Humans; Luciferases; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Oxides; Signal Transduction; Xenograft Model Antitumor Assays | 2015 |
ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction underlie apoptosis induced by resveratrol and arsenic trioxide in A549 cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Lung; Lung Neoplasms; Mitochondria; Oxides; Reactive Oxygen Species; Resveratrol; Stilbenes | 2016 |
[Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Caspase 3; Drug Synergism; Glutathione; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Oxidation-Reduction; Oxides; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2016 |
Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Artemisinins; Bronchi; Cell Cycle Checkpoints; Cell Survival; DNA Damage; Epithelial Cells; Humans; Lung Neoplasms; Oxides; Reactive Oxygen Species | 2017 |
Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Cell Line, Tumor; G2 Phase; Glutathione; Humans; Lung Neoplasms; Oxides; Reactive Oxygen Species; Superoxides | 2008 |
Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyelocytic leukaemia.
Topics: Adenocarcinoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Arsenites; Auranofin; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Oxides; Protein Biosynthesis; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; RNA, Small Interfering; Selenium Radioisotopes; Selenoproteins; Sodium Compounds; Sodium Selenite; Thioredoxin Reductase 1 | 2008 |
Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Nucleus; Cell Survival; Colorectal Neoplasms; Cytoplasmic Structures; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Formazans; Humans; Mice; Mice, Nude; Oxides; Polymerase Chain Reaction; Telomerase; Tetrazolium Salts; Xenograft Model Antitumor Assays | 2008 |
Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; G2 Phase; Gene Expression Regulation, Leukemic; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Promyelocytic, Acute; Metaphase; Neoplasm Proteins; Oxides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-cbl; Signal Transduction; Stomach Neoplasms; Tumor Suppressor Protein p53; Ubiquitination; Up-Regulation | 2009 |
[Effect of arsenic trioxide combined with aspirin on the growth of human gastric adenocarcinoma graft in nude mice].
Topics: Adenocarcinoma; Animals; Arsenic Trioxide; Arsenicals; Aspirin; bcl-2-Associated X Protein; Humans; Ki-67 Antigen; Mice; Mice, Nude; Neoplasm Transplantation; Oxides; Proto-Oncogene Proteins c-bcl-2; Stomach Neoplasms | 2009 |
Arsenic trioxide inhibits the growth of human lung cancer cell lines via cell cycle arrest and induction of apoptosis at both normoxia and hypoxia.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Cell Hypoxia; Cell Line; Cyclin B; Cyclin B1; Cyclin-Dependent Kinases; Down-Regulation; Humans; Lung Neoplasms; Oxides; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 2009 |
The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Topics: Adenocarcinoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Drug Synergism; Glutathione; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitogen-Activated Protein Kinases; Oxides; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Reactive Oxygen Species | 2009 |
Effects of arsenic trioxide on cell death, reactive oxygen species and glutathione levels in different cell types.
Topics: Adenocarcinoma; Animals; Arsenic Trioxide; Arsenicals; Cattle; Cell Death; Cell Line; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Glutathione; Growth Inhibitors; HeLa Cells; Humans; Lung Neoplasms; Oxides; Reactive Oxygen Species | 2010 |
Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.
Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Dose-Response Relationship, Drug; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Lung; Lung Neoplasms; Mice; Mice, SCID; Oxides; Polymorphism, Single Nucleotide; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering | 2014 |
[Arsenic trioxide enhances TRAIL inducing human lung cancer cell line A549 cells apoptosis by down-regulate the expression of NF-kappaB].
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; NF-kappa B; Oxides; TNF-Related Apoptosis-Inducing Ligand | 2012 |
[Effect and mechanism of arsenic trioxide on chemosensitivity of human lung adenocarcinoma cells].
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Oxides; Proto-Oncogene Proteins c-bcl-2; Vault Ribonucleoprotein Particles | 2003 |
Arsenic trioxide causes redistribution of cell cycle, caspase activation, and GADD expression in human colonic, breast, and pancreatic cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 3; Caspases; CCAAT-Enhancer-Binding Proteins; Cell Cycle; Cell Cycle Proteins; Cell Division; Colonic Neoplasms; DNA Fragmentation; Enzyme Activation; Gene Expression Regulation; Genes, bcl-2; Growth Inhibitors; Humans; In Situ Nick-End Labeling; Neoplasm Proteins; Nuclear Proteins; Oxides; Pancreatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured | 2004 |
[Toxicity of arsenic trioxide to human lung adenocarcinoma cell line SPCA1 and its mechanism].
Topics: Adenocarcinoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Calcium; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; fas Receptor; Humans; Inhibitory Concentration 50; Lung Neoplasms; Oxides; Proto-Oncogene Proteins c-bcl-2 | 2004 |
Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; Humans; Oxides; Stomach Neoplasms | 2005 |
Mitogen-activated protein kinases mediate arsenic-induced down-regulation of survivin in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Drug Antagonism; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Oxides; Poly(ADP-ribose) Polymerases; Survivin | 2006 |
Improved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal models.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation; Carcinoma, Renal Cell; Catheter Ablation; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Laser-Doppler Flowmetry; Mice; Mice, Nude; Neoplasms, Experimental; Oxides; Rabbits; Rats; Rats, Inbred F344; Regional Blood Flow; Sarcoma | 2006 |
Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia.
Topics: Adenocarcinoma; Adult; Aged; Arsenic Trioxide; Arsenicals; Colonic Neoplasms; Female; Growth Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Male; Nasopharyngeal Neoplasms; Neoplasms; Oxides | 2007 |
[Reversal effect and mechanism of arsenic trioxide on multidrug resistance of gastric carcinoma cells SGC7901].
Topics: Adenocarcinoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluorouracil; Glutathione Transferase; Humans; Oxides; Stomach Neoplasms; Vincristine | 2007 |
[Effects of arsenic trioxide on apoptosis and proliferation of human lung cancer cells under hypoxia].
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Humans; Lung Neoplasms; Oxides | 2008 |
[Experimental study on combination of Ad-p53 with CDDP or As(2)O(3) in human lung adenocarcinoma cell line GLC-82].
Topics: Adenocarcinoma; Adenoviridae; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cisplatin; Combined Modality Therapy; Disease Models, Animal; Genetic Therapy; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Oxides; Transfection; Transplants; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2000 |